Progress of labour with hyoscine-n-butyl bromide: a randomized double-blind placebo-controlled study
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR201908521430230
- Lead Sponsor
- Fagbohun
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 172
Multiparous pregnant women aged 18-40 years, with singleton pregnancy in cephalic presentation, admitted in active phase (at cervical dilatation of 4 to 6 cm) of spontaneous labour at term (37 weeks – 41 weeks + 6 days gestation) whose rate of cervical dilatation is less than 1 cm per hour as assessed four hours into admission
Grand multiparity
Multiple pregnancy
Previous uterine scar
Cervical dilation = 7 cm at admission
Cervical cerclage
Chronic or pregnancy induced medical conditions
Presence of any contraindication to vaginal delivery
Allergy to hyoscine-n-butyl bromide
History suggestive of, or previous diagnoses of glaucoma, myasthenia gravis, obstructive uropathy, asthma, cardiac, liver or renal disease, seizure disorder or psychiatric illness
Prolonged Prelabour rupture of the fetal membranes (rupture of fetal membrane with latency period greater than 24hrs)
Congenital fetal malformations
Intra uterine growth restriction (IUGR)
Cephalopelvic disproportion
Intrauterine fetal death (IUFD)
Non consenting patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method